Related Experiment Video
Updated: Jan 19, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Present and Future in Treatment of Hodgkin Lymphoma
Andrei Turbatu1, Andrei Colita1, Ana-Maria Bordea1
1Clinic of Hematology, Coltea Clinical Hospital, Bucharest, Romania.
Abstract:
Hodgkin lymphoma is a highly curable malignant hemopathy, using chemotherapy, radiotherapy, target therapies and hematopoietic stem cell transplantation. Current research in this field focuses on identifying prognostic factors associated with the pathogenic characteristics of the tumoral process, enabling the therapy to be adjusted to each patient's degree of risk. The identification of biomarkers associated with the tumoral process is extremely important because these molecules can be targets for new biological therapies.
Related Concept Videos
08:53Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
07:12Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Future Value
Understanding future value offers several benefits. For example, it helps in making informed investment decisions. By projecting investment growth, individuals can compare financial products...
10:52Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
08:31Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
04:23Determining the Role of Neutrophil-Like Cells in Lymphoma Cell Sensitivity to a Test Drug

